Stock listing
LS Exchange:A2AFXS Corvus Pharmaceuticals, Inc. Aktie
German listing (LS Exchange) of Corvus Pharmaceuticals, Inc. · home listing NASDAQ:CRVS
Follow Corvus Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CRVS
$10.03 USD -0.20 (-2.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CRVS
- Day range
- $9.78 – $10.37 USDOct 30, 2026
- Volume
- 845,085 sharesOct 30, 2026
- Market cap
- $843.7M USDAt the close on Oct 30, 2026 · price × 84.12M shares outstanding
- 52-week range
- $6.39 – $26.95 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $12.24M USDMedian day 939,100 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CRVS · Home | $10.03 USD | -0.20 (-2.0%) | 845,085 | $10.09 | $10.37 | $9.78 | $10.23 | Close on Oct 30, 2026 |
| Frankfurt:C17 | €8.652 EUR | -0.79 (-8.4%) | — | €8.652 | €8.652 | €8.652 | €9.442 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CRVS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $10.03 | -0.20 | -2.0% | $10.09 | $10.37 | $9.78 | 845,085 | |
| $10.23 | -0.29 | -2.8% | $10.57 | $10.74 | $10.18 | 852,138 | |
| $10.52 | -0.02 | -0.2% | $10.40 | $10.70 | $10.29 | 911,663 | |
| $10.54 | +0.09 | +0.9% | $10.49 | $10.80 | $10.31 | 1,132,702 | |
| $10.45 | -0.08 | -0.8% | $10.54 | $10.61 | $10.35 | 981,128 | |
| $10.53 | -0.12 | -1.1% | $10.58 | $10.65 | $10.08 | 933,657 | |
| $10.65 | +0.60 | +6.0% | $9.92 | $10.68 | $9.85 | 1,080,556 | |
| $10.05 | -0.18 | -1.8% | $10.25 | $10.59 | $10.00 | 868,812 | |
| $10.23 | +0.58 | +6.0% | $9.67 | $10.33 | $9.65 | 1,066,930 | |
| $9.65 | +0.13 | +1.4% | $9.73 | $10.00 | $9.50 | 820,335 | |
| $9.52 | -0.33 | -3.4% | $9.81 | $10.12 | $9.433 | 1,035,600 | |
| $9.85 | +0.47 | +5.0% | $9.49 | $10.07 | $9.36 | 1,000,200 | |
| $9.38 | -0.03 | -0.3% | $9.31 | $9.50 | $9.21 | 976,800 | |
| $9.41 | -0.64 | -6.4% | $9.99 | $10.03 | $9.32 | 1,685,600 | |
| $10.05 | -0.47 | -4.5% | $10.43 | $10.52 | $10.02 | 719,700 | |
| $10.52 | +0.31 | +3.0% | $10.21 | $10.71 | $10.08 | 1,032,300 | |
| $10.21 | -0.20 | -1.9% | $10.15 | $10.31 | $9.82 | 1,881,000 | |
| $10.41 | -0.15 | -1.4% | $10.25 | $10.65 | $10.25 | 1,157,100 | |
| $10.56 | -0.18 | -1.7% | $10.75 | $10.96 | $10.20 | 1,441,100 | |
| $10.74 | -0.16 | -1.5% | $10.88 | $11.15 | $10.45 | 823,700 | |
| $10.90 | -0.03 | -0.3% | $11.11 | $11.11 | $10.64 | 1,347,800 | |
| $10.93 | -0.59 | -5.1% | $11.56 | $11.75 | $10.89 | 1,306,900 | |
| $11.52 | -0.24 | -2.0% | $12.00 | $12.03 | $11.50 | 875,700 | |
| $11.76 | -0.11 | -0.9% | $12.37 | $12.42 | $11.72 | 881,900 | |
| $11.87 | +0.25 | +2.2% | $11.66 | $12.12 | $11.25 | 1,210,200 | |
| $11.62 | -0.18 | -1.5% | $11.92 | $12.04 | $11.42 | 1,099,600 | |
| $11.80 | -0.74 | -5.9% | $12.46 | $12.48 | $11.51 | 1,141,600 | |
| $12.54 | -0.90 | -6.7% | $13.30 | $13.45 | $12.25 | 945,200 | |
| $13.44 | +1.02 | +8.2% | $12.55 | $13.46 | $12.35 | 805,300 | |
| $12.42 | -0.14 | -1.1% | $12.80 | $12.80 | $12.28 | 939,800 | |
| $12.56 | +0.01 | +0.1% | $12.53 | $12.61 | $12.25 | 4,460,300 | |
| $12.55 | +0.32 | +2.6% | $12.55 | $12.82 | $12.43 | 1,534,800 | |
| $12.23 | -0.72 | -5.6% | $13.00 | $13.15 | $12.18 | 952,000 | |
| $12.95 | -0.16 | -1.2% | $13.07 | $13.17 | $12.45 | 1,397,100 | |
| $13.11 | +0.20 | +1.5% | $12.92 | $13.31 | $12.91 | 1,088,500 | |
| $12.91 | -0.03 | -0.2% | $13.13 | $13.50 | $12.77 | 1,257,600 | |
| $12.94 | -0.39 | -2.9% | $13.06 | $13.14 | $12.82 | 1,094,700 | |
| $13.33 | -0.60 | -4.3% | $13.76 | $13.91 | $12.95 | 1,106,800 | |
| $13.93 | -0.46 | -3.2% | $14.01 | $14.32 | $13.85 | 1,032,900 | |
| $14.39 | -0.26 | -1.8% | $14.34 | $14.74 | $14.34 | 626,900 | |
| $14.65 | +0.45 | +3.2% | $14.38 | $14.72 | $13.98 | 938,400 | |
| $14.20 | -0.07 | -0.5% | $14.38 | $14.82 | $13.87 | 619,900 | |
| $14.27 | +0.23 | +1.6% | $13.86 | $14.30 | $13.84 | 460,100 | |
| $14.04 | -0.12 | -0.8% | $14.09 | $14.16 | $13.71 | 883,000 | |
| $14.16 | -0.56 | -3.8% | $14.60 | $14.60 | $13.98 | 644,500 | |
| $14.72 | -0.01 | -0.1% | $14.74 | $15.14 | $14.62 | 508,100 | |
| $14.73 | +0.17 | +1.2% | $14.55 | $15.04 | $14.34 | 692,800 | |
| $14.56 | +0.47 | +3.3% | $14.30 | $14.83 | $14.30 | 642,200 | |
| $14.09 | -0.37 | -2.6% | $14.37 | $14.37 | $13.79 | 513,500 | |
| $14.46 | +0.13 | +0.9% | $14.52 | $14.76 | $14.38 | 473,700 | |
| $14.33 | -1.07 | -6.9% | $15.15 | $15.31 | $14.14 | 783,500 | |
| $15.40 | +0.57 | +3.8% | $15.20 | $15.72 | $14.94 | 846,300 | |
| $14.83 | -0.08 | -0.5% | $14.75 | $15.14 | $14.61 | 635,100 | |
| $14.91 | +0.02 | +0.1% | $14.82 | $15.23 | $14.68 | 506,000 | |
| $14.89 | -0.25 | -1.7% | $14.99 | $15.19 | $14.61 | 777,900 | |
| $15.14 | +0.09 | +0.6% | $15.25 | $15.44 | $14.91 | 1,007,100 | |
| $15.05 | +0.32 | +2.2% | $14.80 | $15.29 | $14.74 | 1,025,100 | |
| $14.73 | +0.99 | +7.2% | $13.92 | $14.76 | $13.60 | 834,500 | |
| $13.74 | -0.18 | -1.3% | $13.82 | $14.19 | $13.43 | 944,300 | |
| $13.92 | +0.06 | +0.4% | $12.90 | $14.00 | $12.80 | 1,370,100 | |
| $13.86 | -0.07 | -0.5% | $13.82 | $14.45 | $13.71 | 578,300 | |
| $13.93 | +0.01 | +0.1% | $14.08 | $14.29 | $13.74 | 738,900 | |
| $13.92 | +0.55 | +4.1% | $13.67 | $14.10 | $13.41 | 766,900 | |
| $13.37 | +0.11 | +0.8% | $13.17 | $13.52 | $12.91 | 580,800 | |
| $13.26 | +0.07 | +0.5% | $13.24 | $13.37 | $12.81 | 775,900 | |
| $13.19 | +0.15 | +1.2% | $13.15 | $13.33 | $12.92 | 963,000 |
- Ticker
- LS Exchange:A2AFXS
- Asset type
- Stock
- Exchange
- LS Exchange
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026
Latest earnings call · Aug 6, 2026
Corvus Pharmaceuticals (NASDAQ:CRVS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Q2 2026 Earnings Presentation
Earnings · 26 slides
Calls
Upcoming
Corvus Pharmaceuticals (NASDAQ:CRVS) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Register
Replays
Corvus Pharmaceuticals (NASDAQ:CRVS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptCorvus Pharmaceuticals (NASDAQ:CRVS) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 4:30 PM ET
Watch TranscriptCorvus Pharmaceuticals (NASDAQ:CRVS) Q3 2025 Earnings Call
Tue, Nov 04, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026
Oct 29, 2026
Closed $10.23 (-2.8%) on Oct 29, 2026
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
Sep 30, 2026
Closed $10.93 (-5.1%) on Oct 1, 2026
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
Sep 3, 2026
Closed $14.65 (+3.2%) on Sep 3, 2026
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
Aug 27, 2026
Closed $14.72 (-0.1%) on Aug 27, 2026
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $13.92 (+0.4%) on Aug 7, 2026
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
Jul 30, 2026
Closed $13.26 (+0.5%) on Jul 31, 2026
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
Jun 9, 2026
Closed $11.17 (+0.2%) on Jun 9, 2026
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
May 20, 2026
Closed $13.08 (+7.3%) on May 21, 2026
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
May 7, 2026
Closed $15.55 (+6.6%) on May 8, 2026
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
Apr 23, 2026
Closed $16.02 (-10.3%) on Apr 23, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 26 slides · Aug 6, 2026
Society for Investigative Dermatology 2026
Conference · 19 slides · May 2026
Technical Presentation (May 2026)
Technical · 14 slides · May 2026
Q4 2025 Earnings Presentation
Earnings · 37 slides · Mar 12, 2026
Corvus Pharmaceuticals, Inc. on 6ix
- News releases
- 23 in the last 12 months · 123 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 14 calls with a replay · 14 with a transcript · latest Aug 6, 2026
- Decks
- 13 decks · latest Aug 6, 2026
Where Corvus Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CRVS · Home listing | NASDAQ | United States | USD |
| gettex:C17 | gettex | Germany | EUR |
| LS Exchange:A2AFXS · This page | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2AFXS | Lang & Schwarz | Germany | EUR |
| Tradegate:C17 | Tradegate | Germany | EUR |
| BOATS:CRVS | BOATS | United States | USD |
| Dusseldorf:C17 | Dusseldorf | Germany | EUR |
| Frankfurt:C17 | Frankfurt | Germany | EUR |
| Hamburg:C17 | Hamburg | Germany | EUR |
| Munich:C17 | Munich | Germany | EUR |
| BX Swiss:C17 | BX Swiss | Switzerland | CHF |
| Stuttgart:C17 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Corvus Pharmaceuticals, Inc.